Education
About Us
Working with TipRanks
Follow Us
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
JAGSNPHARM Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹126.00 - ₹328.02
Previous CloseN/A
Volume94.85K
Average Volume (3M)19.51K
Market Cap
₹14.26B
Enterprise Value₹7.49B
Total Cash (Recent Filing)₹1.29B
Total Debt (Recent Filing)₹92.39M
Price to Earnings (P/E)26.0
Beta1.14
Next Earnings
Aug 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 06, 2024Dividend Yield0.93%
Share Statistics
EPS (TTM)0.98
Shares Outstanding66,473,480
10 Day Avg. Volume7,414
30 Day Avg. Volume19,506
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)0.67
Price to Sales (P/S)0.00
P/FCF Ratio2.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
JAGSNPHARM FAQ
What was Jagsonpal Pharmaceuticals Ltd.’s price range in the past 12 months?
Jagsonpal Pharmaceuticals Ltd. lowest stock price was ₹126.00 and its highest was ₹328.02 in the past 12 months.
What is Jagsonpal Pharmaceuticals Ltd.’s market cap?
Jagsonpal Pharmaceuticals Ltd.’s market cap is ₹14.26B.
When is Jagsonpal Pharmaceuticals Ltd.’s upcoming earnings report date?
Jagsonpal Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 07, 2025 which is in 45 days.
How were Jagsonpal Pharmaceuticals Ltd.’s earnings last quarter?
Jagsonpal Pharmaceuticals Ltd. released its earnings results on May 06, 2025. The company reported ₹0.98 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.98.
Is Jagsonpal Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Jagsonpal Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Jagsonpal Pharmaceuticals Ltd. pay dividends?
Jagsonpal Pharmaceuticals Ltd. pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.93%. See more information on Jagsonpal Pharmaceuticals Ltd. dividends here
What is Jagsonpal Pharmaceuticals Ltd.’s EPS estimate?
Jagsonpal Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jagsonpal Pharmaceuticals Ltd. have?
Jagsonpal Pharmaceuticals Ltd. has 66,473,480 shares outstanding.
What happened to Jagsonpal Pharmaceuticals Ltd.’s price movement after its last earnings report?
Jagsonpal Pharmaceuticals Ltd. reported an EPS of ₹0.98 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.439%.
Which hedge fund is a major shareholder of Jagsonpal Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:JAGSNPHARM
Technical Analysis
Bajaj Healthcare Ltd
―
Bliss Gvs Pharma Limited
―
Hester Biosciences Limited
―
Lincoln Pharmaceuticals Ltd
―
Themis Medicare Limited
―